Pfizer (PFE)

21.87 -0.17  -0.77%  May 31, 5:20PM Go Pro
Watch this stock

Pfizer Performance

Historical performance is a good guide for the future, but it is imperfect. Pay attention to a company's history, but be realistic about what you can project into the future.

5 Year Total Returns Performance

Returns from price appreciation only give a partial view of the returns to an investor. This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested)

Returns -20.44%

1 Year Total Returns Performance Comparison

Here are Pfizer's total returns compared to the market and some of its peers. High historical total returns are excellent - especially if you held the stock at the time - but returns can change direction quickly. To predict future performance, looking at the business is more important than looking at historic returns.

  • PFE Total Returns
  • ^SPXTR Total Returns
  • GSK Total Returns
  • MRK Total Returns
1 month total returns YTD total returns 1 year total returns* 3 year total returns
PFE -3.55% 3.12% 6.26% 64.23%
^SPXTR -5.81% 5.38% 0.88% 52.09%
GSK -3.53% -0.47% 7.08% 53.37%
MRK -4.23% 0.79% 7.04% 56.09%

* May differ from chart if one year ago today was not a trading day. Table uses the previous trading day as a base while chart uses the next trading day.

Fundamental Performance

Price vs Earnings

In the long run, the price and earnings of a company are correlated. If the two metrics are diverging, there should be a good reason why. Divergence without reason can signal danger or opportunity.

Price -20.44%
Earnings Per Share TTM -49.38%

Earnings Yield vs Dividend Yield

Yields show how much you are getting for the price you pay. For example, an earnings yield of 8% means that for every dollar you pay, you get 8 cents worth of current earnings. Take these numbers into account when buying to see if you are over-paying or getting a good deal.

Earnings Yield 5.62%
Dividend Yield 4.03%

Revenue and Earnings Growth

Revenues show how much the company is selling to customers, while net income is what remains for shareholders after the company pays its expenses. Revenue growth often persists over time, but net income is more fickle. Watch closely to see if revenue and income grow at similar rates.

Revenues TTM 66.33B
Net Income TTM 9.581B

Efficent Use of Assets

Profit margins show what percentage of every dollar of sales turns into earnings. Asset Uitlization shows how many dollars of sales a company gets for each dollar that the company invests in assets. Multiplying the two numbers together gives you Return on Assets which tells you approximately how efficiently the company invests money to earn more money.

Profit Margin 11.65%
Asset Utilization 0.3476

Reinvestment Strategy

Return on Invested Capital (ROIC) tells you how much income a company earned after investing $1 in its business. The Payout Ratio tells what percentage of the company's income it pays to shareholders instead of reinvesting in its own growth. Watch out for companies that pay out very little when their ROIC is low.

5 Year Average ROIC 0.0902
5 Year Average Payout Ratio 0.8072
Get Performance for

PFE News

ASCO 2012 Preview
May 31, 6:57PM Fool
15 Great Stocks with Great Yield
May 31, 3:40PM Benzinga
Big Bets on MS
May 31, 3:29PM Fool
$AMRN I would be surprised if $PFE isn't having backchannel talks pre-889.$AMRN is a perfect takeout...very few employees and cinch approval
about 7 hours ago by InTheBarn
Is the NASDAQ on Sale?
May 31, 11:10AM
5 Defensive Plays for Long Term Investors
May 31, 11:00AM Investor Place
Drug Stocks In The Spotlight At ASCO Conference. $JNJ $CELG $ONXX $RHHBY $PFE http://stks.co/42e8
about 17 hours ago by abubnic
@SciGuy $DRRX I don't believe so; the fortunes of DURECT are tied to $PFE and Remoxy
about 20 hours ago by SlownSteady
The Tale of 2 Patents
May 30, 10:36PM Fool
@SCarolinaguy $DRRX licensed the drug to $PTIE; $PTIE licensed it to King and $PFE bought King; I think people might forget about $DRRX
about 21 hours ago by SlownSteady
@SlownSteady Sounds encouraging with $PFE supporting. What is the relationship? Surely their support would lead to approval
about 21 hours ago by SCarolinaguy
@SCarolinaguy $DRRX $PFE plans to resubmit the NDA. The company has other products; a recent filed trial triggered share price punishment
about 21 hours ago by SlownSteady
@SCarolinaguy $DRRX Only insiders know. CMC problems are usually resolved. $PFE will have new data and meet with the FDA
about 21 hours ago by SlownSteady
Antares Pharma is undervalued at this level by bad Grecce /Spain Market however $AIS , $PFE, $WPI , $ISIS , $ARNA , $AMRN
about a day ago by BioInvestor
Keep a Close Eye on VIVUS
May 30, 3:00PM Fool
2 of 3 Best Performers in Dow are unchanged. $PFE, $T
about a day ago by frotuss
Dow Best Performers $WMT .12 $T .03 $PFE .01 Hey, that's awesome!
about a day ago by frotuss
Still a Bear Market http://stks.co/41w8 $KFT $MCD $MRK $MSFT $PFE $KO
about a day ago by LouisEbner
Who Should Buy Amylin?
May 29, 11:37AM Fool
Top 6 Stocks to Buy for June
May 29, 11:15AM Investor Place
RT @Glopolon: Does it matter, they are next door to $PFE $AMRN /i live next to a lawyer. odds of being sued increased day they moved in. Hmm
about 4 days ago by ITradeforMe
@troygrim @Bleedblue Does it matter, they are next door to $PFE $AMRN
about 4 days ago by Glopolon
RT @Glopolon $AMRN $PFE 'I wanna get close to you' Rose Royce http://stks.co/404L <Hmmmmmmmm!?$$$
about 4 days ago by Bleedblue
$AMRN $PFE 'I wanna get close to you' Rose Royce http://stks.co/404H
about 4 days ago by Glopolon
$AMRN dont have a dollar figure but Cafe Pharma had an interesting post on $PFE and $AMRN
about 4 days ago by StanD
@SomeGuy900 @christy155 $DRXX If $PFE gets a class 2 resubmission, they'll know in Q2/Q3 of next year; class one they'll know in Q1/Q2 '13
about 5 days ago by SlownSteady
@SomeGuy900 @christy155 $DRXX The $PFE discussions with the FDA should be in Q3; I imagine they will resubmit in early 2013
about 5 days ago by SlownSteady
$SPY $PFE wow - what a dead stock - surely there is good reason $$
about 5 days ago by WorldJazz59
@SomeGuy900 @christy155 The last comment from $DRRX management was that $PFE was getting ready to talk to the FDA about some more studies
about 5 days ago by SlownSteady
@SomeGuy900 @christy155 $DRRX I have no idea what's going on. It's gone up 20 cents since I bought in. Maybe $PFE will talk with the FDA
about 5 days ago by SlownSteady
Antares Pharma is undervalued at this level by bad Grecce market $AIS , $PFE, $WPI , $ISIS , $ARNA , $AMRN
about 5 days ago by BioInvestor
Best Dogs Of The Dow Jones As Of May 2012 + http://stks.co/3zos + $T $VZ $MRK $PFE $GE $JNJ $PG $DD $CVX $JPM
about 6 days ago by DividendYield
Shorter Timeframe, More Risky
May 24, 3:11PM Fool
Bull Case for Mannkind
May 24, 2:00PM Fool
Is Bristol a Buy Post-Plavix
May 23, 5:38PM Fool
Why Johnson & Johnson is a Buy
May 21, 10:40AM Fool
Eaton Scoops up Cooper Industries for $11.8B
May 21, 10:00AM Fox Business

Recent Quotes

Symbol Price Chg Chg % Market Cap
PFE 21.87 -0.17 -0.77% 166.12B
PETM 64.47 +0.02 +0.03% 7.082B
PETD 24.80 +0.06 +0.22% 584.84M
PERY 18.82 -0.07 -0.37% 296.95M
PERI 3.86 -0.19 -4.69% 40.18M
PERF 7.80 -0.01 -0.13% 70.06M
PER 19.93 -0.07 -0.35% 787.60M
PEP 67.99 -0.23 -0.34% 108.30B
PEOP 16.08 +0.33 +2.10%
PEO 23.01 -0.18 -0.78%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close